Jun 24 |
TScan Therapeutics Decline Means Insider Profits Down To US$54k
|
Jun 24 |
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
|
Jun 14 |
TScan Therapeutics Announces Updates to its Board of Directors
|
May 30 |
TScan Therapeutics Announces Upcoming Presentation at the Jefferies Global Healthcare Conference
|
May 29 |
TScan Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for its Two Lead TCR-T Therapy Candidates for the Treatment of Heme Malignancies
|
May 14 |
TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations
|
May 13 |
TScan Therapeutics GAAP EPS of -$0.32, revenue of $0.56M
|
May 13 |
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
|
May 13 |
Key Takeaways From TScan Therapeutics Analyst Ratings
|
May 13 |
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
|